ANURAS Stock Overview
Engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Anupam Rasayan India Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹718.70 |
| 52 Week High | ₹1,106.30 |
| 52 Week Low | ₹672.80 |
| Beta | 0.21 |
| 1 Month Change | -1.76% |
| 3 Month Change | -3.90% |
| 1 Year Change | -28.74% |
| 3 Year Change | -20.58% |
| 5 Year Change | n/a |
| Change since IPO | 36.43% |
Recent News & Updates
Anupam Rasayan India's (NSE:ANURAS) Problems Go Beyond Weak Profit
Nov 25
Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
Nov 18Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02Recent updates
Anupam Rasayan India's (NSE:ANURAS) Problems Go Beyond Weak Profit
Nov 25Earnings Report: Anupam Rasayan India Ltd Missed Revenue Estimates By 9.2%
Nov 18Anupam Rasayan India (NSE:ANURAS) Hasn't Managed To Accelerate Its Returns
Nov 02Time To Worry? Analysts Just Downgraded Their Anupam Rasayan India Ltd (NSE:ANURAS) Outlook
Aug 24Anupam Rasayan India Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 17Anupam Rasayan India's (NSE:ANURAS) Shareholders Have More To Worry About Than Only Soft Earnings
May 26Analyst Estimates: Here's What Brokers Think Of Anupam Rasayan India Limited (NSE:ANURAS) After Its Full-Year Report
May 22What You Can Learn From Anupam Rasayan India Ltd's (NSE:ANURAS) P/E
Dec 30Anupam Rasayan India (NSE:ANURAS) Might Have The Makings Of A Multi-Bagger
Nov 03Is Now The Time To Put Anupam Rasayan India (NSE:ANURAS) On Your Watchlist?
Jul 13Anupam Rasayan India's (NSE:ANURAS) Returns On Capital Are Heading Higher
Jun 24We Ran A Stock Scan For Earnings Growth And Anupam Rasayan India (NSE:ANURAS) Passed With Ease
Apr 06Earnings Update: Here's Why Analysts Just Lifted Their Anupam Rasayan India Ltd. (NSE:ANURAS) Price Target To ₹988
Jul 28Anupam Rasayan India's (NSE:ANURAS) Promising Earnings May Rest On Soft Foundations
May 20If You Like EPS Growth Then Check Out Anupam Rasayan India (NSE:ANURAS) Before It's Too Late
May 13Returns At Anupam Rasayan India (NSE:ANURAS) Appear To Be Weighed Down
Mar 31Investors Interested In Anupam Rasayan India Limited's (NSE:ANURAS) Earnings
Mar 07Shareholder Returns
| ANURAS | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -4.8% | -2.5% | -2.1% |
| 1Y | -28.7% | 8.5% | 22.5% |
Return vs Industry: ANURAS underperformed the Indian Chemicals industry which returned 8.5% over the past year.
Return vs Market: ANURAS underperformed the Indian Market which returned 22.5% over the past year.
Price Volatility
| ANURAS volatility | |
|---|---|
| ANURAS Average Weekly Movement | 3.1% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ANURAS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ANURAS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,896 | Gopal Agrawal | www.anupamrasayan.com |
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients.
Anupam Rasayan India Ltd Fundamentals Summary
| ANURAS fundamental statistics | |
|---|---|
| Market cap | ₹78.97b |
| Earnings (TTM) | ₹699.03m |
| Revenue (TTM) | ₹12.45b |
113.0x
P/E Ratio6.3x
P/S RatioIs ANURAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ANURAS income statement (TTM) | |
|---|---|
| Revenue | ₹12.45b |
| Cost of Revenue | ₹5.14b |
| Gross Profit | ₹7.31b |
| Other Expenses | ₹6.61b |
| Earnings | ₹699.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.36 |
| Gross Margin | 58.72% |
| Net Profit Margin | 5.62% |
| Debt/Equity Ratio | 43.0% |
How did ANURAS perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield12%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 22:26 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Anupam Rasayan India Ltd is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ankur Periwal | Axis Capital Limited |
| Rohit Nagraj | Centrum Broking Limited |
| Satish Kumar | CGS International |